D-dimer Testing Market 2027 Growing Worldwide By Best Key players- Thermo Fisher Scientific Inc.; F. Hoffmann-La Roche Ltd.; Siemen Healthineers; Abbott; biomérieux SA; WERFEN; HORIBA, Ltd.; Quidel Corporation; Diazyme Laboratories, Inc.; Biomedica Diagnostics; Sekisui Diagnostics
The global D-dimer testing market size is expected to reach USD 1.7 billion by 2027 , expanding at a CAGR of 4.3%, according to a new report by Grand View Research, Inc. Technological advancements in D-dimer testing have resulted in the development of a wide range of products that have allowed healthcare professionals to offer suitable emergency assistance to patients. The concept of automation in D-dimer testing has provided rapid, less labor-intensive, and user-friendly diagnostic strategies, which is expected to drive the market in the near future. The commercially available assays often have differences in their antibody specificity as D-dimer antibodies also detect Fibrin Degradation Products (FDPs), leading to incorrect results. To address this issue, Advanced ImmunoChemical, Inc. has developed two monoclonal antibodies, which are used to design one-step immunoassay specific for both FDP and D-dimer. Thus, the development of improved immunoassays that equally detect all FDPs